BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1187 related articles for article (PubMed ID: 33693810)

  • 21. Single Dose of an mRNA Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) Vaccine Is Associated With Lower Nasopharyngeal Viral Load Among Nursing Home Residents With Asymptomatic Coronavirus Disease 2019 (COVID-19).
    McEllistrem MC; Clancy CJ; Buehrle DJ; Lucas A; Decker BK
    Clin Infect Dis; 2021 Sep; 73(6):e1365-e1367. PubMed ID: 33768222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Routine asymptomatic testing strategies for airline travel during the COVID-19 pandemic: a simulation study.
    Kiang MV; Chin ET; Huynh BQ; Chapman LAC; Rodríguez-Barraquer I; Greenhouse B; Rutherford GW; Bibbins-Domingo K; Havlir D; Basu S; Lo NC
    Lancet Infect Dis; 2021 Jul; 21(7):929-938. PubMed ID: 33765417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review.
    Talasaz AH; Sadeghipour P; Kakavand H; Aghakouchakzadeh M; Kordzadeh-Kermani E; Van Tassell BW; Gheymati A; Ariannejad H; Hosseini SH; Jamalkhani S; Sholzberg M; Monreal M; Jimenez D; Piazza G; Parikh SA; Kirtane AJ; Eikelboom JW; Connors JM; Hunt BJ; Konstantinides SV; Cushman M; Weitz JI; Stone GW; Krumholz HM; Lip GYH; Goldhaber SZ; Bikdeli B
    J Am Coll Cardiol; 2021 Apr; 77(15):1903-1921. PubMed ID: 33741176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitigating staff shortages: Risk of permitting healthcare workers to return to work after coronavirus disease 2019 (COVID-19) exposure.
    Monsalud CFL; Lind MFG; Hines CM; Schora D; Grant J; McElvania E; Singh K
    Infect Control Hosp Epidemiol; 2022 Jun; 43(6):827-828. PubMed ID: 33736733
    [No Abstract]   [Full Text] [Related]  

  • 25. Outbreak of coronavirus disease 2019 (COVID-19) among operating room staff of a tertiary referral center: An epidemiologic and environmental investigation.
    McDougal AN; Elhassani D; DeMaet MA; Shores S; Plante KS; Plante JA; Pyles R; Weaver SC; Williams-Bouyer N; Tyler BJ; Davis HR; Patel J
    Infect Control Hosp Epidemiol; 2022 Mar; 43(3):319-325. PubMed ID: 33736732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistence of SARS-CoV-2 N-Antibody Response in Healthcare Workers, London, UK.
    Shrotri M; Harris RJ; Rodger A; Planche T; Sanderson F; Mahungu T; McGregor A; Heath PT; ; Brown CS; Dunning J; Hopkins S; Ladhani S; Chand M
    Emerg Infect Dis; 2021 Apr; 27(4):1155-1158. PubMed ID: 33734962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Children in Summer Schools Applying Stringent Control Measures in Barcelona, Spain.
    Jordan I; Fernandez de Sevilla M; Fumado V; Bassat Q; Bonet-Carne E; Fortuny C; Garcia-Miquel A; Jou C; Adroher C; Melé Casas M; Girona-Alarcon M; Hernández Garcia M; Pons Tomas G; Ajanovic S; Arias S; Balanza N; Baro B; Millat-Martinez P; Varo R; Alonso S; Álvarez-Lacalle E; López D; Claverol J; Cubells M; Brotons P; Codina A; Cuadras D; Bruijning-Verhagen P; Faust S; Munro A; Muñoz-Almagro C; Català M; Prats C; Garcia-Garcia JJ; Gratacós E
    Clin Infect Dis; 2022 Jan; 74(1):66-73. PubMed ID: 33709138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies.
    Collier DA; De Marco A; Ferreira IATM; Meng B; Datir RP; Walls AC; Kemp SA; Bassi J; Pinto D; Silacci-Fregni C; Bianchi S; Tortorici MA; Bowen J; Culap K; Jaconi S; Cameroni E; Snell G; Pizzuto MS; Pellanda AF; Garzoni C; Riva A; ; Elmer A; Kingston N; Graves B; McCoy LE; Smith KGC; Bradley JR; Temperton N; Ceron-Gutierrez L; Barcenas-Morales G; ; Harvey W; Virgin HW; Lanzavecchia A; Piccoli L; Doffinger R; Wills M; Veesler D; Corti D; Gupta RK
    Nature; 2021 May; 593(7857):136-141. PubMed ID: 33706364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial.
    Ella R; Reddy S; Jogdand H; Sarangi V; Ganneru B; Prasad S; Das D; Raju D; Praturi U; Sapkal G; Yadav P; Reddy P; Verma S; Singh C; Redkar SV; Gillurkar CS; Kushwaha JS; Mohapatra S; Bhate A; Rai S; Panda S; Abraham P; Gupta N; Ella K; Bhargava B; Vadrevu KM
    Lancet Infect Dis; 2021 Jul; 21(7):950-961. PubMed ID: 33705727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From Asymptomatic and Presymptomatic Individuals in Healthcare Settings Despite Medical Masks and Eye Protection.
    Klompas M; Baker MA; Griesbach D; Tucker R; Gallagher GR; Lang AS; Fink T; Cumming M; Smole S; Madoff LC; Rhee C
    Clin Infect Dis; 2021 Nov; 73(9):1693-1695. PubMed ID: 33704451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of 3 Versus 6 ft of Physical Distancing for Controlling Spread of Coronavirus Disease 2019 Among Primary and Secondary Students and Staff: A Retrospective, Statewide Cohort Study.
    van den Berg P; Schechter-Perkins EM; Jack RS; Epshtein I; Nelson R; Oster E; Branch-Elliman W
    Clin Infect Dis; 2021 Nov; 73(10):1871-1878. PubMed ID: 33704422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19.
    Stephenson KE; Le Gars M; Sadoff J; de Groot AM; Heerwegh D; Truyers C; Atyeo C; Loos C; Chandrashekar A; McMahan K; Tostanoski LH; Yu J; Gebre MS; Jacob-Dolan C; Li Z; Patel S; Peter L; Liu J; Borducchi EN; Nkolola JP; Souza M; Tan CS; Zash R; Julg B; Nathavitharana RR; Shapiro RL; Azim AA; Alonso CD; Jaegle K; Ansel JL; Kanjilal DG; Guiney CJ; Bradshaw C; Tyler A; Makoni T; Yanosick KE; Seaman MS; Lauffenburger DA; Alter G; Struyf F; Douoguih M; Van Hoof J; Schuitemaker H; Barouch DH
    JAMA; 2021 Apr; 325(15):1535-1544. PubMed ID: 33704352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Shedding of Culturable Virus, Seroconversion, and 6-Month Follow-up Antibody Responses in the First 14 Confirmed Cases of Coronavirus Disease 2019 in the United States.
    Killerby ME; Ata Ur Rasheed M; Tamin A; Harcourt JL; Abedi GR; Lu X; Kujawski S; Shah MM; Kirking HL; Gold JAW; Salvatore PP; Coughlin MM; Whitaker B; Tate JE; Watson JT; Lindstrom S; Hall AJ; Fry AM; Gerber SI; Midgley CM; Thornburg NJ
    J Infect Dis; 2021 Sep; 224(5):771-776. PubMed ID: 33693830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines.
    Chapin-Bardales J; Gee J; Myers T
    JAMA; 2021 Jun; 325(21):2201-2202. PubMed ID: 33818592
    [No Abstract]   [Full Text] [Related]  

  • 35. BNT 13b2 Pfizer vaccine protects against SARS-CoV-2 respiratory mucosal colonization even after prolonged exposure to positive family members.
    Edelstein S; Tannous S; Jacobs MT; Ben-Amram H; Zarka S
    J Hosp Infect; 2021 Jul; 113():192-194. PubMed ID: 33811961
    [No Abstract]   [Full Text] [Related]  

  • 36. Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers.
    Tré-Hardy M; Cupaiolo R; Papleux E; Wilmet A; Horeanga A; Antoine-Moussiaux T; Della Vecchia A; Beukinga I; Vekemans M; Blairon L
    J Infect; 2021 Aug; 83(2):237-279. PubMed ID: 33811939
    [No Abstract]   [Full Text] [Related]  

  • 37. SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies.
    Hoffmann M; Arora P; Groß R; Seidel A; Hörnich BF; Hahn AS; Krüger N; Graichen L; Hofmann-Winkler H; Kempf A; Winkler MS; Schulz S; Jäck HM; Jahrsdörfer B; Schrezenmeier H; Müller M; Kleger A; Münch J; Pöhlmann S
    Cell; 2021 Apr; 184(9):2384-2393.e12. PubMed ID: 33794143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular complications of SARS-CoV-2 infection (COVID-19): a systematic review and meta-analysis.
    Zhao YH; Zhao L; Yang XC; Wang P
    Rev Cardiovasc Med; 2021 Mar; 22(1):159-165. PubMed ID: 33792257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SARS-CoV-2 infection and the COVID-19 pandemic: a call to action for therapy and interventions to resolve the crisis of hospitalization, death, and handle the aftermath.
    McCullough PA; Vijay K
    Rev Cardiovasc Med; 2021 Mar; 22(1):9-10. PubMed ID: 33792243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early impact of school closure and social distancing for COVID-19 on the number of inpatients with childhood non-COVID-19 acute infections in Japan.
    Kishimoto K; Bun S; Shin JH; Takada D; Morishita T; Kunisawa S; Imanaka Y
    Eur J Pediatr; 2021 Sep; 180(9):2871-2878. PubMed ID: 33791861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 60.